- call +1-201-465-4211
- email sales@mrinsights.biz
Filgrastim is a granulocyte colony-stimulating factor in humans and a hematopoietic agent utilized for prevention of infection and neutropenic (low count of WBCs) fevers triggered by chemotherapy, HIV/AIDS, radiation poisoning, or others. Filgrastim can be administered by subcutaneous injection or infused into vein by IV.
Scope of the Report:
This report focuses on the Filgrastim in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Filgrastim is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Cadila Pharmaceuticals
Abbott
Dr. Reddy's
Intas Biopharmaceuticals
Amgen
Emcure Pharmaceuticals
Reliance Life Sciences
Sandoz(Novartis)
Biocon
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
In-House Manufacturing
Contract Manufacturing Organizations
Market Segment by Applications, can be divided into
Oncology
Chronic and Autoimmune Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Applications
There are 15 Chapters to deeply display the global Filgrastim market.
Chapter 1, to describe Filgrastim Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Filgrastim, with sales, revenue, and price of Filgrastim, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Filgrastim, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Filgrastim market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Filgrastim sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Filgrastim Introduction
1.2 Market Analysis by Type
1.2.1 In-House Manufacturing
1.2.2 Contract Manufacturing Organizations
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Chronic and Autoimmune Diseases
1.3.3 Blood Disorders
1.3.4 Growth Hormone Deficiency
1.3.5 Infectious Diseases
1.3.6 Other Applications
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Cadila Pharmaceuticals
2.1.1 Business Overview
2.1.2 Filgrastim Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Cadila Pharmaceuticals Filgrastim Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott
2.2.1 Business Overview
2.2.2 Filgrastim Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbott Filgrastim Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Dr. Reddy's
2.3.1 Business Overview
2.3.2 Filgrastim Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Dr. Reddy's Filgrastim Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Intas Biopharmaceuticals
2.4.1 Business Overview
2.4.2 Filgrastim Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Intas Biopharmaceuticals Filgrastim Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Amgen
2.5.1 Business Overview
2.5.2 Filgrastim Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Amgen Filgrastim Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Emcure Pharmaceuticals
2.6.1 Business Overview
2.6.2 Filgrastim Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Emcure Pharmaceuticals Filgrastim Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Reliance Life Sciences
2.7.1 Business Overview
2.7.2 Filgrastim Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Reliance Life Sciences Filgrastim Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sandoz(Novartis)
2.8.1 Business Overview
2.8.2 Filgrastim Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sandoz(Novartis) Filgrastim Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Biocon
2.9.1 Business Overview
2.9.2 Filgrastim Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Biocon Filgrastim Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Filgrastim Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Filgrastim Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Filgrastim Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Filgrastim Manufacturer Market Share in 2017
3.3.2 Top 6 Filgrastim Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Filgrastim Market Analysis by Regions
4.1 Global Filgrastim Sales, Revenue and Market Share by Regions
4.1.1 Global Filgrastim Sales and Market Share by Regions (2013-2018)
4.1.2 Global Filgrastim Revenue and Market Share by Regions (2013-2018)
4.2 North America Filgrastim Sales and Growth Rate (2013-2018)
4.3 Europe Filgrastim Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Filgrastim Sales and Growth Rate (2013-2018)
4.5 South America Filgrastim Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Filgrastim Sales and Growth Rate (2013-2018)
5 North America Filgrastim by Countries
5.1 North America Filgrastim Sales, Revenue and Market Share by Countries
5.1.1 North America Filgrastim Sales and Market Share by Countries (2013-2018)
5.1.2 North America Filgrastim Revenue and Market Share by Countries (2013-2018)
5.2 United States Filgrastim Sales and Growth Rate (2013-2018)
5.3 Canada Filgrastim Sales and Growth Rate (2013-2018)
5.4 Mexico Filgrastim Sales and Growth Rate (2013-2018)
6 Europe Filgrastim by Countries
6.1 Europe Filgrastim Sales, Revenue and Market Share by Countries
6.1.1 Europe Filgrastim Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Filgrastim Revenue and Market Share by Countries (2013-2018)
6.2 Germany Filgrastim Sales and Growth Rate (2013-2018)
6.3 UK Filgrastim Sales and Growth Rate (2013-2018)
6.4 France Filgrastim Sales and Growth Rate (2013-2018)
6.5 Russia Filgrastim Sales and Growth Rate (2013-2018)
6.6 Italy Filgrastim Sales and Growth Rate (2013-2018)
7 Asia-Pacific Filgrastim by Countries
7.1 Asia-Pacific Filgrastim Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Filgrastim Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Filgrastim Revenue and Market Share by Countries (2013-2018)
7.2 China Filgrastim Sales and Growth Rate (2013-2018)
7.3 Japan Filgrastim Sales and Growth Rate (2013-2018)
7.4 Korea Filgrastim Sales and Growth Rate (2013-2018)
7.5 India Filgrastim Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Filgrastim Sales and Growth Rate (2013-2018)
8 South America Filgrastim by Countries
8.1 South America Filgrastim Sales, Revenue and Market Share by Countries
8.1.1 South America Filgrastim Sales and Market Share by Countries (2013-2018)
8.1.2 South America Filgrastim Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Filgrastim Sales and Growth Rate (2013-2018)
8.3 Argentina Filgrastim Sales and Growth Rate (2013-2018)
8.4 Colombia Filgrastim Sales and Growth Rate (2013-2018)
9 Middle East and Africa Filgrastim by Countries
9.1 Middle East and Africa Filgrastim Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Filgrastim Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Filgrastim Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Filgrastim Sales and Growth Rate (2013-2018)
9.3 UAE Filgrastim Sales and Growth Rate (2013-2018)
9.4 Egypt Filgrastim Sales and Growth Rate (2013-2018)
9.5 Nigeria Filgrastim Sales and Growth Rate (2013-2018)
9.6 South Africa Filgrastim Sales and Growth Rate (2013-2018)
10 Global Filgrastim Market Segment by Type
10.1 Global Filgrastim Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Filgrastim Sales and Market Share by Type (2013-2018)
10.1.2 Global Filgrastim Revenue and Market Share by Type (2013-2018)
10.2 In-House Manufacturing Sales Growth and Price
10.2.1 Global In-House Manufacturing Sales Growth (2013-2018)
10.2.2 Global In-House Manufacturing Price (2013-2018)
10.3 Contract Manufacturing Organizations Sales Growth and Price
10.3.1 Global Contract Manufacturing Organizations Sales Growth (2013-2018)
10.3.2 Global Contract Manufacturing Organizations Price (2013-2018)
11 Global Filgrastim Market Segment by Application
11.1 Global Filgrastim Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Chronic and Autoimmune Diseases Sales Growth (2013-2018)
11.4 Blood Disorders Sales Growth (2013-2018)
11.5 Growth Hormone Deficiency Sales Growth (2013-2018)
11.6 Infectious Diseases Sales Growth (2013-2018)
11.7 Other Applications Sales Growth (2013-2018)
12 Filgrastim Market Forecast (2018-2023)
12.1 Global Filgrastim Sales, Revenue and Growth Rate (2018-2023)
12.2 Filgrastim Market Forecast by Regions (2018-2023)
12.2.1 North America Filgrastim Market Forecast (2018-2023)
12.2.2 Europe Filgrastim Market Forecast (2018-2023)
12.2.3 Asia-Pacific Filgrastim Market Forecast (2018-2023)
12.2.4 South America Filgrastim Market Forecast (2018-2023)
12.2.5 Middle East and Africa Filgrastim Market Forecast (2018-2023)
12.3 Filgrastim Market Forecast by Type (2018-2023)
12.3.1 Global Filgrastim Sales Forecast by Type (2018-2023)
12.3.2 Global Filgrastim Market Share Forecast by Type (2018-2023)
12.4 Filgrastim Market Forecast by Application (2018-2023)
12.4.1 Global Filgrastim Sales Forecast by Application (2018-2023)
12.4.2 Global Filgrastim Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Filgrastim Picture
Table Product Specifications of Filgrastim
Figure Global Sales Market Share of Filgrastim by Types in 2017
Table Filgrastim Types for
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
